abstract |
The present invention provides sorbitol crystals and methods for augmenting such crystals. The present invention also provides a method for designing specific ligands based on the crystal structure of sorbitol. The present invention also relates to the preparation and use of such ligands for the manufacture of a medicament for the treatment of diseases, injuries or disorders of the central and peripheral nervous systems. |